COMMUNIQUÉS West-GlobeNewswire

Nox Peptides Introduces Educational Resources and Research Tools for Peptide Science
29/09/2026
TORONTO, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Nox Peptides has introduced a collection of educational resources and practical research tools designed to help readers and researchers better understand peptide science and [...]
Portsmouth Square, Inc. Reports Fiscal 2026 Results; Hotel Revenue Increases 20% Year-Over-Year and Operating Performance Strengthens as San Francisco Recovery Progresses
29/09/2026
Los Angeles, California, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Portsmouth Square, Inc. (the "Company" or "Portsmouth") financial results for the fiscal year ended June 30, 2026. Portsmouth operates in two reportable [...]
Regulated information: Disclosure of a transparency notification from BlackRock, Inc.
29/09/2026
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 29 September 2026 – 6 PM CET Disclosure of a transparency notification from BlackRock, Inc. Pursuant to the Belgian act of 2 May 2007 on the [...]
Vivoryon Therapeutics N.V. Reports Outcome of 2026 Annual General Meeting
29/09/2026
Vivoryon Therapeutics N.V. Reports Outcome of 2026 Annual General Meeting Halle (Saale) / Munich, Germany, September 29 , 2026 - Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) ( Vivoryon ), a [...]
RESTEM to Present at the 2026 Cell & Gene Meeting on the Mesa
29/09/2026
MIAMI, Sept. 29, 2026 (GLOBE NEWSWIRE) -- RESTEM – a clinical-stage biotechnology company that develops off-the-shelf, next-generation cell therapies designed to modulate the immune system, today announced that Chief [...]
Aro Biotherapeutics Appoints Biotechnology Executive Brett Blackman, Ph.D., to its Board of Directors
29/09/2026
PHILADELPHIA, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Aro Biotherapeutics, a clinical-stage biotechnology company developing targeted short-interfering RNA (siRNA) medicines for the treatment of diseases with high unmet [...]
Oncolytics Biotech® Announces Publication Demonstrating Pelareorep Creates Immune Responses in Liver Cancer That Make Tumors Susceptible to Immunotherapy
29/09/2026
Data support pelareorep’s potential as a backbone therapy to transform immunologically inactive liver tumors into a phenotype that will respond to immune-based intervention SAN DIEGO, Sept. 29, 2026 (GLOBE NEWSWIRE) -- [...]
Ernexa Therapeutics Selected for Emerging Track at 2026 Cell & Gene Meeting on the Mesa, Highlighting ERNA-101 and Focused Oncology Strategy
29/09/2026
Ernexa selected for the Emerging Track, recognizing the Company among emerging innovators in the cell and gene therapy sector President & CEO Sanjeev Luther to deliver an Innovation Spotlight presentation on October [...]
SafeSpace Global Advances Addiction Treatment Vertical with Signed Statement of Work and Initial Antidote Health Ventures Deployment
29/09/2026
Agreement Moves Previously Announced Antidote Partnership into Paid Deployment KNOXVILLE, Tenn., Sept. 29, 2026 (GLOBE NEWSWIRE) -- SafeSpace Global Corporation (OTCID: SSGC) (“SafeSpace Global” or the “Company”), a [...]
Simone Biles Partners with Arcutis to Launch the Skin to Believe In Campaign, Raising Awareness of Seborrheic Dermatitis and Eczema, and Inspiring People to Explore Treatment Options
29/09/2026
Simone Biles opens up about her experience managing the symptoms of these conditions and encourages long-term control of skin health Biles’ treatment, ZORYVE ® (roflumilast), is the #1 prescribed branded topical therapy [...]
Standard Dental Labs Files Semiannual Report and Projects Annualized Revenue of 3.48 Times 2025 Revenue
29/09/2026
Management estimates $822,000 in annualized revenue as SDL expands digital production capabilities and appoints Dr. David Zionts as its first advisor ORLANDO, Fla., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Standard Dental [...]
TETmedical Names Arjun Ishwar Chief Commercial Officer to Lead Commercial Strategy and Accelerate NSE-FAST® Toward Market Launch and Rapid Growth
29/09/2026
Veteran MedTech Commercial Builder Who Has Scaled Businesses from First Dollar to $100M+ in Revenue, Secured Coverage and Reimbursement Pathways, and Led International Expansion Joins TETmedical Ahead of Its Pivotal [...]
Liminatus Pharma Regains Compliance with Nasdaq Minimum Bid Price Rule
29/09/2026
FULLERTON, Calif., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Liminatus Pharma, Inc. (Nasdaq: LIMN) (“Liminatus” or the “Company”) today announced that the Company has regained compliance with Nasdaq’s minimum bid price rule. [...]
Tiny Health Raises $33M Series B to Establish Microbiome Intelligence as the Standard of Care
29/09/2026
Led by B Capital, the round will accelerate Tiny Health’s mission to make the gut microbiome measurable, accessible, and actionable, becoming central to precision health across the lifespan AUSTIN, Texas, Sept. 29, 2026 [...]
Nexalin Technology Taps Neuromodulation Commercial Executive Robert DiTota to Advise on its Global Commercialization Strategy
29/09/2026
Appointment as Senior Strategic Advisor marks the Company’s expansion from clinical development toward commercialization of its DIFS™ platform in the United States, Europe and South America DiTota spent over two decades [...]
10X Health Earns NSF Certified for Sport® Certification for its 10X Creatine and 10X Amino Blend Products
29/09/2026
The public health organization’s rigorous independent certification includes testing for potentially harmful levels of contaminants and 300+ athletic banned substances SCOTTSDALE, Ariz., Sept. 29, 2026 (GLOBE NEWSWIRE [...]
With Fusion™ Denture Family, Dandy Sets a New Standard of Care
29/09/2026
First-of-its-kind manufacturing process delivers the handcrafted aesthetics of traditional dentures with the precision of digital design NEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Dandy , the fully digital dental lab [...]
H1 Selected by CMS to Help Build a Trusted National Foundation for Provider Information
29/09/2026
H1’s provider intelligence platform, relied on by millions of Americans each year to find a doctor, will help support CMS’s goal of more accurate, accessible provider information for patients, providers, payers, and the [...]
NeOnc’s Powerful Brain Cancer Pipeline Advances
29/09/2026
November 17 FDA Meeting Could Define the Next Phase for NEO212 DALLAS, Sept. 29, 2026 (GLOBE NEWSWIRE) -- ( www.InvestorsTape.com ) -- NeOnc Technologies Holdings (NASDAQ: NTHI) is heading toward another potentially [...]

Pages